Attached files

file filename
8-K - SUN HEALTHCARE GROUP INCform8k.htm
EXHIBIT 99.1
 
Sun Healthcare Group, Inc.
Reports 2012 Second-quarter Operating Results;
Normalized EPS from Continuing Operations of $0.15

Contact: Investor Inquiries (505) 468-2341
Media Inquiries (505) 468-4582

Irvine, Calif. (July 31, 2012)—Sun Healthcare Group, Inc. (NASDAQ GS: SUNH) today announced its operating results for the second quarter ended June 30, 2012.

Highlights of continuing operations:

·  
consolidated revenues were $457.1 million for the quarter, down 2.9 percent as compared to the same period in 2011;
·  
consolidated normalized adjusted EBITDAR was $56.2 million for the quarter representing a normalized adjusted EBITDAR margin of 12.3 percent; and
·  
normalized earnings per share was $0.15 for the quarter.

Segment Updates
 
Revenue from Sun’s inpatient services business totaled $405.1 million in the second quarter, down $13.4 million, or 3.2 percent, from the second quarter of 2011. The year-over-year decrease in revenues resulted principally from the reduction in Medicare rates as mandated by the CMS Final Rule and implemented on October 1, 2011. Overall patient volumes remained stable at 87.2 percent occupancy for the quarter, consistent with occupancy in both the year-over-year and sequential quarters. The decrease in revenues further resulted in a decrease in adjusted EBITDAR for inpatient services, partially offset by the company’s ongoing cost mitigation activities. Adjusted EBITDAR for the quarter was $66.3 million, down $10.9 million or 14.1 percent from the prior year second quarter, while adjusted EBITDAR margin for the quarter was 16.4 percent, down 200 basis points from the prior year second quarter.
 
As previously disclosed, the Company classified certain operations within its inpatient services business as discontinued. Financial results from these operations are reflected in discontinued operations in Sun’s income statement and excluded from its discussion of ongoing operations.  Discontinued operations include eight skilled nursing centers and one assisted living center located in the Oklahoma and Rhode Island markets. Discontinued operations include the losses incurred from operating those discontinued centers. The Company is seeking to sell the discontinued centers to unaffiliated third-party operators.
 
Included in the inpatient services business segment are $15.9 million of revenues from SolAmor, Sun’s hospice division, which experienced year-over-year revenue growth of $1.0 million or 6.5 percent in the quarter. SolAmor’s adjusted EBITDAR was $3.8 million in the second quarter and adjusted EBITDAR margin was 24.2 percent.
 
           SunDance, Sun’s rehabilitation therapy services business, reported second-quarter revenues of $62.0 million, adjusted EBITDAR of $4.0 million and an adjusted EBITDAR margin of 6.4 percent, up 40 basis points year over year. Ongoing changes to SunDance’s therapy-delivery processes in response to the CMS Final Rule continued to mitigate the rule’s impact.

 
 

 
 
           CareerStaff, Sun’s medical staffing services business, reported revenues of $23.5 million, up 3.6 percent year over year, adjusted EBITDAR of $2.0 million and adjusted EBITDAR margin of 8.6 percent, up 60 basis points year over year. On a sequential quarter basis, CareerStaff experienced 2.7 percent revenue growth while billable hours increased on both a sequential quarter and year-over-year basis for the second quarter in a row.
 
Cash Flow
 
At June 30, 2012, Sun had $43.6 million in cash and cash equivalents and $89.2 million of long-term debt. During the second quarter, Sun generated cash flow from operations of $7.0 million and used $7.9 million of cash for capital investments. On a normalized basis, operating cash flow for the quarter was $12.9 million after adding back the $5.9 million of Medicaid funds which were temporarily held back by Massachusetts in June 2012 but which were subsequently received by Sun in July 2012.
 
Transaction Update; Withdrawal of Guidance
 
The Company filed its definitive proxy statement concerning the transaction with Genesis HealthCare with the Securities and Exchange Commission on July 24, 2012. The Company has commenced mailing the proxy statement to stockholders of the Company and will hold a special stockholders meeting concerning the transaction on September 5, 2012. As previously announced, the closing is expected to occur in the fall. In connection with the transaction, the Company incurred $1.8 million of transaction costs through the six months ended June 30, 2012, which were primarily comprised of legal fees and financial advisory fees. Due to the pending transaction with Genesis HealthCare, the Company is withdrawing its 2012 financial guidance. As previously announced, the Company will not hold a quarterly conference call to discuss its second-quarter results.
 
Additional Information and Where to Find It
 
In connection with the proposed transaction with Genesis HealthCare, the Company has filed a proxy statement and other relevant documents concerning the transaction with the Securities and Exchange Commission (“SEC”). Investors and stockholders of the Company are urged to read the definitive proxy statement and other relevant documents because they will contain important information about the transaction. Copies of these documents may be obtained free of charge by making a request to the Company’s Investor Relations Department either in writing to Sun Healthcare Group, Inc., 101 Sun Avenue, N.E., Albuquerque, New Mexico 87109, or by telephone to (505) 468-2341. In addition, documents filed with the SEC by the Company may be obtained free of charge at the SEC’s website at www.sec.gov or by clicking on “SEC Filings” on the Company’s website at www.sunh.com.
 
The Company and its directors, executive officers and certain employees may be deemed to be participants in the solicitation of proxies from the Company’s stockholders in respect of the transaction. Information concerning the ownership of the Company’s securities by the Company’s directors and executive officers is included in their SEC filings on Forms 3, 4 and 5, and additional information is also available in the Company’s definitive proxy statement in connection with the proposed transaction.
 
About Sun Healthcare Group, Inc.
 
           Sun Healthcare Group, Inc. (NASDAQ: SUNH) is a healthcare services company, serving principally the senior population, with consolidated annual revenues in excess of $1.9 billion and approximately 28,000 employees in 46 states. Sun's services are provided through its subsidiaries: as of June 30, 2012, SunBridge Healthcare and its subsidiaries’ continuing operations include 158 skilled nursing centers, 13 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and seven mental health centers with an aggregate of 21,349 licensed beds in 23 states; SunDance Rehabilitation provides rehabilitation therapy services to affiliated and non-affiliated centers in 36 states; CareerStaff Unlimited provides medical staffing

 
 

 

services in 40 states; and SolAmor Hospice provides hospice services in 11 states. For more information, go to www.sunh.com.
 
Forward-looking Statements
 
           Statements made in this release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "anticipate," "believe," "plan," "estimate," "expect," "hope," "intend," "may" and similar expressions. Forward-looking statements in this release include all statements regarding the expected continuing effect of the Company’s cost-mitigation and therapy-delivery plans to mitigate the impact on the Company’s business of the CMS Final Rule and the Company’s expectations regarding the closing of the transaction with Genesis Healthcare. Factors that could cause actual results to differ are identified in filings made by the Company with the Securities and Exchange Commission and include changes in Medicare and Medicaid reimbursements, including with respect to the CMS Final Rule, and the Company’s ability to mitigate the impact of such changes; the impact that healthcare reform legislation will have on the Company's business; the ability to maintain the occupancy rates and payor mix at the Company's healthcare centers; potential liability for losses not covered by, or in excess of, insurance; the effects of government regulations and investigations; the ability of the Company to collect its accounts receivable on a timely basis; the amount of the Company's indebtedness; covenants in debt agreements and leases that may restrict the Company's activities, including the Company's ability to make acquisitions and incur more indebtedness on favorable terms; the impact of the economic downturn on the business; increasing labor costs and the shortage of qualified healthcare personnel; the Company's ability to receive increases in reimbursement rates from government payors to cover increased costs; delays in or failure to satisfy required conditions to the closing of the proposed merger with Genesis Healthcare, including the receipt of required regulatory approvals with respect to the transaction and approval of the acquisition by the Company’s stockholders; failure to consummate or delay in consummating the transaction for other reasons; and disruption from the transaction making it more difficult to maintain relationships with customers and employees. More information on factors that could affect the Company's business and financial results are included in Sun's filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun's web site, www.sunh.com. There may be additional risks of which the Company is presently unaware or that it currently deems immaterial.

               The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company’s control. Sun cautions investors that any forward-looking statements made by Sun are not guarantees of future performance and are only made as of the date of this release. Sun disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

           EBITDA, adjusted EBITDA, adjusted EBITDAR and free cash flow, as used in this press release and in the accompanying tables, which are non-GAAP financial measures, are each reconciled to their respective GAAP-recognized financial measures in the accompanying tables.  


# # #

 
 

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
KEY INCOME STATEMENT FIGURES
CONSOLIDATED
(in thousands, except per share data)
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
             
             
Revenue
  $ 457,142     $ 470,575  
                 
Center rent expense
    36,522       35,750  
                 
Depreciation and amortization
    8,504       7,629  
                 
Interest expense, net
    4,429       4,854  
                 
Pre-tax income
    4,874       19,339  
                 
Income tax expense
    1,901       7,894  
                 
Income from continuing operations
    2,973       11,445  
                 
Loss from discontinued operations
    (3,953 )     (1,499 )
                 
Net (loss) income
  $ (980 )   $ 9,946  
                 
                 
Diluted (loss) income per share
  $ (0.04 )   $ 0.38  
                 
                 
                 
Adjusted EBITDAR
  $ 54,329     $ 67,739  
Margin - Adjusted EBITDAR
    11.9 %     14.4 %
                 
Adjusted EBITDAR normalized
  $ 56,167     $ 67,739  
Margin - Adjusted EBITDAR normalized
    12.3 %     14.4 %
                 
                 
                 
                 
Adjusted EBITDA
  $ 17,807     $ 31,989  
Margin - Adjusted EBITDA
    3.9 %     6.8 %
                 
Adjusted EBITDA normalized
  $ 19,645     $ 31,989  
Margin - Adjusted EBITDA normalized
    4.3 %     6.8 %
                 
                 
                 
                 
Pre-tax income continuing operations - normalized
  $ 6,712     $ 19,339  
                 
Income tax expense - normalized
  $ 2,618     $ 7,894  
                 
Income from continuing operations - normalized
  $ 4,094     $ 11,445  
                 
Diluted earnings per share from continuing operations - normalized
  $ 0.15     $ 0.44  
                 
                 
                 
    See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to  
    Adjusted EBITDA and Adjusted EBITDAR."
 
   
    See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison."
 
                 


 
1 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
KEY INCOME STATEMENT FIGURES
CONSOLIDATED
(in thousands, except per share data)
             
   
For the
   
For the
 
   
Six Months Ended
   
Six Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
             
             
Revenue
  $ 915,635     $ 936,883  
                 
Center rent expense
    72,899       71,442  
                 
Depreciation and amortization
    16,934       15,077  
                 
Interest expense, net
    8,839       9,853  
                 
Pre-tax income
    7,921       35,575  
                 
Income tax expense
    3,089       14,512  
                 
Income from continuing operations
    4,832       21,063  
                 
Loss from discontinued operations
    (5,599 )     (3,005 )
                 
Net (loss) income
  $ (767 )   $ 18,058  
                 
                 
Diluted (loss) income per share
  $ (0.03 )   $ 0.70  
                 
                 
                 
Adjusted EBITDAR
  $ 106,593     $ 132,250  
Margin - Adjusted EBITDAR
    11.6 %     14.1 %
                 
Adjusted EBITDAR normalized
  $ 108,431     $ 132,250  
Margin - Adjusted EBITDAR normalized
    11.8 %     14.1 %
                 
                 
                 
                 
Adjusted EBITDA
  $ 33,694     $ 60,808  
Margin - Adjusted EBITDA
    3.7 %     6.5 %
                 
Adjusted EBITDA normalized
  $ 35,532     $ 60,808  
Margin - Adjusted EBITDA normalized
    3.9 %     6.5 %
                 
                 
                 
                 
Pre-tax income continuing operations - normalized
  $ 9,759     $ 35,575  
                 
Income tax expense - normalized
  $ 3,806     $ 14,512  
                 
Income from continuing operations - normalized
  $ 5,953     $ 21,063  
                 
Diluted earnings per share from continuing operations - normalized
  $ 0.22     $ 0.81  
                 
                 
                 
    See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to
 
         Adjusted EBITDA and Adjusted EBITDAR."
               
                 
    See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison."
 


 
2 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
             
             
   
June 30, 2012
   
December 31, 2011
 
   
(unaudited)
   
(unaudited)
 
ASSETS
           
             
Current assets:
           
Cash and cash equivalents
  $ 43,648     $ 57,908  
Restricted cash
    14,330       15,706  
Accounts receivable, net
    212,831       202,229  
Prepaid expenses and other assets
    27,093       29,075  
Assets held for sale
    4,537       -  
Deferred tax assets
    63,018       63,170  
                 
 Total current assets
    365,457       368,088  
                 
Property and equipment, net
    145,673       148,298  
Intangible assets, net
    33,991       35,294  
Goodwill
    34,905       34,496  
Restricted cash, non-current
    354       353  
Deferred tax assets
    124,382       123,974  
Other assets
    43,152       45,163  
 
               
Total assets
  $ 747,914     $ 755,666  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Current liabilities:
               
Accounts payable
  $ 44,603     $ 55,888  
Accrued compensation and benefits
    63,878       61,101  
Accrued self-insurance obligations, current portion
    57,628       57,810  
Other accrued liabilities
    47,638       43,139  
Current portion of long-term debt and capital lease obligations
    967       1,017  
                 
Total current liabilities
    214,714       218,955  
                 
Accrued self-insurance obligations, net of current portion
    155,048       157,267  
Long-term debt and capital lease obligations, net of current portion
    88,242       88,768  
Unfavorable lease obligations, net
    5,880       7,110  
Other long-term liabilities
    56,107       58,110  
                 
Total liabilities
    519,991       530,210  
                 
                 
Stockholders' equity:
               
Preferred stock of $.01 par value, authorized 3,333 shares,
zero shares were issued and outstanding as of June 30, 2012
    and December 31, 2011
    -       -  
Common stock of $.01 par value, authorized 41,667 shares,
        25,535 and 25,146 shares issued and outstanding as of
       June 30, 2012 and December 31, 2011, respectively
    255       251  
Additional paid-in capital
    730,242       726,861  
Accumulated deficit
    (501,194 )     (500,427 )
Accumulated other comprehensive loss, net
    (1,380 )     (1,229 )
      227,923       225,456  
Total liabilities and stockholders' equity
  $ 747,914     $ 755,666  
                 

 
3 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share data)
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
   
(unaudited)
   
(unaudited)
 
             
Total net revenues
  $ 457,142     $ 470,575  
Costs and expenses:
               
Operating salaries and benefits
    259,506       263,461  
Self-insurance for workers' compensation and
      general and professional liability insurance
    13,190       14,541  
Operating administrative costs
    11,703       13,305  
Other operating costs
    95,429       92,159  
Center rent expense
    36,522       35,750  
General and administrative expenses
    16,048       14,952  
Depreciation and amortization
    8,504       7,629  
Provision for losses on accounts receivable
    5,099       4,418  
Interest, net of interest income of $67 and $82, respectively
    4,429       4,854  
Transaction costs
    1,838       -  
Restructuring costs
    -       167  
Total costs and expenses
    452,268       451,236  
                 
Income before income taxes and discontinued operations
    4,874       19,339  
Income tax expense
    1,901       7,894  
Income from continuing operations
    2,973       11,445  
                 
Loss from discontinued operations, net
    (3,953 )     (1,499 )
                 
Net (loss) income
  $ (980 )   $ 9,946  
                 
                 
Basic loss per common and common equivalent share:
               
Income from continuing operations
  $ 0.11     $ 0.44  
Loss from discontinued operations, net
    (0.15 )     (0.06 )
Net (loss) income
  $ (0.04 )   $ 0.38  
                 
Diluted loss per common and common equivalent share:
               
Income from continuing operations
  $ 0.11     $ 0.44  
Loss from discontinued operations, net
    (0.15 )     (0.06 )
Net (loss) income
  $ (0.04 )   $ 0.38  
                 
Weighted average number of common and
 common equivalent shares outstanding:
         
Basic
    27,039       26,146  
Diluted
    27,039       26,187  

 
4 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share data)
             
   
For the
   
For the
 
   
Six Months Ended
 
Six Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
   
(unaudited)
   
(unaudited)
 
             
Total net revenues
  $ 915,635     $ 936,883  
Costs and expenses:
               
Operating salaries and benefits
    520,595       525,943  
Self-insurance for workers' compensation and
      general and professional liability insurance
    28,507       29,098  
Operating administrative costs
    24,110       26,372  
Other operating costs
    191,995       183,294  
Center rent expense
    72,899       71,442  
General and administrative expenses
    32,089       30,331  
Depreciation and amortization
    16,934       15,077  
Provision for losses on accounts receivable
    9,908       9,595  
Interest, net of interest income of $135 and $140, respectively
    8,839       9,853  
Transaction costs
    1,838       -  
Restructuring costs
    -       303  
Total costs and expenses
    907,714       901,308  
                 
Income before income taxes and discontinued operations
    7,921       35,575  
Income tax expense
    3,089       14,512  
Income from continuing operations
    4,832       21,063  
                 
Loss from discontinued operations, net
    (5,599 )     (3,005 )
                 
Net (loss) income
  $ (767 )   $ 18,058  
                 
                 
Basic loss per common and common equivalent share:
       
Income from continuing operations
  $ 0.18     $ 0.81  
Loss from discontinued operations, net
    (0.21 )     (0.11 )
Net (loss) income
  $ (0.03 )   $ 0.70  
                 
Diluted loss per common and common equivalent share:
 
Income from continuing operations
  $ 0.18     $ 0.81  
Loss from discontinued operations, net
    (0.21 )     (0.11 )
Net (loss) income
  $ (0.03 )   $ 0.70  
                 
Weighted average number of common and
     common equivalent shares outstanding:
 
Basic
    26,542       25,899  
Diluted
    26,542       25,967  
                 

 
5 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
   
(unaudited)
   
(unaudited)
 
             
Cash flows from operating activities:
           
Net (loss) income
  $ (980 )   $ 9,946  
Adjustments to reconcile net (loss) income to net cash provided by
               
  operating activities, including discontinued operations:
               
Depreciation and amortization
    8,504       7,863  
Amortization of favorable and unfavorable lease intangibles
    (507 )     (490 )
Provision for losses on accounts receivable
    5,341       4,860  
Loss on sale of assets, including discontinued operations, net
    69       -  
Stock-based compensation expense
    1,576       1,352  
Deferred taxes
    103       7,944  
Changes in operating assets and liabilities, net of acquisitions:
               
Accounts receivable
    (11,428 )     (7,185 )
Restricted cash
    (6 )     18  
Prepaid expenses and other assets
    573       439  
Accounts payable
    (4,078 )     (1,582 )
Accrued compensation and benefits
    7,384       (4,018 )
Accrued self-insurance obligations
    68       (2,569 )
Income taxes payable
    -       (478 )
Other accrued liabilities
    2,892       (216 )
Other long-term liabilities
    (2,481 )     (492 )
Net cash provided by operating activities
    7,030       15,392  
                 
Cash flows from investing activities:
               
Capital expenditures
    (7,868 )     (9,319 )
Acquisitions, net of cash acquired
    -       (356 )
Net cash used for investing activities
    (7,868 )     (9,675 )
                 
Cash flows from financing activities:
               
Principal repayments of long-term debt and capital lease obligations
    (285 )     (2,800 )
Net cash used for financing activities
    (285 )     (2,800 )
                 
Net (decrease) increase in cash and cash equivalents
    (1,123 )     2,917  
Cash and cash equivalents at beginning of period
    44,771       85,572  
Cash and cash equivalents at end of period
  $ 43,648     $ 88,489  
                 
Reconciliation of net cash provided by operating activities to free cash flow:
         
                 
Net cash provided by operating activities
  $ 7,030     $ 15,392  
Capital expenditures
    (7,868 )     (9,319 )
Free cash flow
  $ (838 )   $ 6,073  
                 
                 
Free cash flow is defined as net cash flow provided by operating activities less cash used for capital expenditures.
Free cash flow is used by management to evaluate discretionary cash flow potentially available for principal repayment and other financing activities.
 
6 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
             
   
For the
   
For the
 
   
Six Months Ended
   
Six Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
   
(unaudited)
   
(unaudited)
 
             
Cash flows from operating activities:
           
Net (loss) income
  $ (767 )   $ 18,058  
Adjustments to reconcile net (loss) income to net cash provided by
           
operating activities, including discontinued operations:
               
Depreciation and amortization
    17,086       15,544  
Amortization of favorable and unfavorable lease intangibles
    (1,020 )     (974 )
Provision for losses on accounts receivable
    10,463       10,504  
Loss on sale of assets, including discontinued operations, net
69       -  
Stock-based compensation expense
    3,808       2,801  
Deferred taxes
    (157 )     9,976  
Changes in operating assets and liabilities, net of acquisitions:
   
Accounts receivable
    (21,209 )     (12,578 )
Restricted cash
    1,375       (1,928 )
Prepaid expenses and other assets
    2,325       190  
Accounts payable
    (10,114 )     (3,501 )
Accrued compensation and benefits
    2,777       (580 )
Accrued self-insurance obligations
    (2,401 )     (3,912 )
Other accrued liabilities
    4,423       (946 )
Other long-term liabilities
    (2,254 )     (1,218 )
Net cash provided by operating activities
    4,404       31,436  
                 
Cash flows from investing activities:
               
Capital expenditures
    (17,829 )     (18,156 )
Acquisitions, net of cash acquired
    (260 )     (356 )
Net cash used for investing activities
    (18,089 )     (18,512 )
                 
Cash flows from financing activities:
               
Borrowings of long-term debt
               
Principal repayments of long-term debt and capital lease obligations
  (575 )     (5,598 )
Net cash used for financing activities
    (575 )     (5,598 )
                 
Net decrease in cash and cash equivalents
    (14,260 )     7,326  
Cash and cash equivalents at beginning of period
    57,908       81,163  
Cash and cash equivalents at end of period
  $ 43,648     $ 88,489  
                 
Reconciliation of net cash provided by operating activities to free cash flow:
         
                 
Net cash provided by operating activities
  $ 4,404     $ 31,436  
Capital expenditures
    (17,829 )     (18,156 )
Free cash flow
  $ (13,425 )   $ 13,280  
                 
                 
 
Free cash flow is defined as net cash flow provided by operating activities less cash used for capital expenditures.
Free cash flow is used by management to evaluate discretionary cash flow potentially available for principal repayment and other financing activities.


 
7 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
(in thousands)
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
   
(unaudited)
   
(unaudited)
 
             
 Total net revenues
  $ 457,142     $ 470,575  
                 
 Net (loss) income
  $ (980 )   $ 9,946  
                 
                 
 Income from continuing operations
    2,973       11,445  
                 
 Income tax expense
    1,901       7,894  
                 
 Interest, net
    4,429       4,854  
                 
 Depreciation and amortization
    8,504       7,629  
                 
 EBITDA
  $ 17,807     $ 31,822  
                 
                 
 Restructuring costs
    -       167  
                 
                 
 Adjusted EBITDA
  $ 17,807     $ 31,989  
                 
 Center rent expense
    36,522       35,750  
                 
 Adjusted EBITDAR
  $ 54,329     $ 67,739  
                 
                 
 
EBITDA is defined as earnings before loss on discontinued operations, income taxes, interest, net, depreciation and amortization.  Adjusted EBITDA is defined as EBITDA before restructuring costs.  Adjusted EBITDAR is defined as Adjusted EBITDA before center rent expense.  Adjusted EBITDA and Adjusted EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole.  Adjusted EBITDA and Adjusted EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability.  Adjusted EBITDA and Adjusted EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles.  As the items excluded from Adjusted EBITDA and Adjusted EBITDAR are significant components in understanding and assessing finance performance, Adjusted EBITDA and Adjusted EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by or used in operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.  Because Adjusted EBITDA and Adjusted EBITDAR are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations.  Adjusted EBITDA and Adjusted EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

 

 
8 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
             
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
 
(in thousands)
             
   
For the
   
For the
 
   
Six Months Ended
   
Six Months Ended
 
   
June 30, 2012
   
June 30, 2011
 
   
(unaudited)
   
(unaudited)
 
             
 Total net revenues
  $ 915,635     $ 936,883  
                 
 Net (loss) income
  $ (767 )   $ 18,058  
                 
                 
 Income from continuing operations
    4,832       21,063  
                 
 Income tax expense
    3,089       14,512  
                 
 Interest, net
    8,839       9,853  
                 
 Depreciation and amortization
    16,934       15,077  
                 
 EBITDA
  $ 33,694     $ 60,505  
                 
 Restructuring costs
    -       303  
                 
                 
 Adjusted EBITDA
  $ 33,694     $ 60,808  
                 
 Center rent expense
    72,899       71,442  
                 
 Adjusted EBITDAR
  $ 106,593     $ 132,250  
                 
                 
 
EBITDA is defined as earnings before loss on discontinued operations, income taxes, interest, net, depreciation and amortization.  Adjusted EBITDA is defined as EBITDA before restructuring costs.  Adjusted EBITDAR is defined as Adjusted EBITDA before center rent expense.  Adjusted EBITDA and Adjusted EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole.  Adjusted EBITDA and Adjusted EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability.  Adjusted EBITDA and Adjusted EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles.  As the items excluded from Adjusted EBITDA and Adjusted EBITDAR are significant components in understanding and assessing finance performance, Adjusted EBITDA and Adjusted EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by or used in operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.  Adjusted EBITDA and Adjusted EBITDAR are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations.  Adjusted EBITDA and Adjusted EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

 
9 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA
and ADJUSTED EBITDAR
($ in thousands)
                                     
For the Three Months Ended June 30, 2012
 (unaudited)
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
 
Consolidated
 
                                     
Nonaffiliated revenue
  $ 405,135     $ 29,197     $ 22,804     $ 6     $ -     $ 457,142  
                                                 
Affiliated revenue
    -       32,804       719       -       (33,523 )     -  
                                                 
Total revenue
  $ 405,135     $ 62,001     $ 23,523     $ 6     $ (33,523 )   $ 457,142  
                                                 
Income (loss) from continuing operations
  $ 22,975     $ 3,551     $ 1,676     $ (25,229 )   $ -     $ 2,973  
                                                 
Income tax expense
    -       -       -       1,901       -       1,901  
                                                 
Interest, net
    (8 )     -       (3 )     4,440       -       4,429  
                                                 
Depreciation and amortization
    7,115       260       187       942       -       8,504  
                                                 
EBITDA
  $ 30,082     $ 3,811     $ 1,860     $ (17,946 )   $ -     $ 17,807  
                                                 
Restructuring costs
    -       -       -       -       -       -  
                                                 
Adjusted EBITDA
  $ 30,082     $ 3,811     $ 1,860     $ (17,946 )   $ -     $ 17,807  
                                                 
Center rent expense
    36,207       145       170       -       -       36,522  
                                                 
Adjusted EBITDAR
  $ 66,289     $ 3,956     $ 2,030     $ (17,946 )   $ -     $ 54,329  
                                                 
                                                 
Normalized Adjusted EBITDA
  $ 30,082     $ 3,811     $ 1,860     $ (16,108 )   $ -     $ 19,645  
Normalized Adjusted EBITDAR
  $ 66,289     $ 3,956     $ 2,030     $ (16,108 )   $ -     $ 56,167  
                                                 
                                                 
Adjusted EBITDA margin
    7.4 %     6.1 %     7.9 %                     3.9 %
                                                 
Adjusted EBITDAR margin
    16.4 %     6.4 %     8.6 %                     11.9 %
                                                 
 Normalized Adjusted EBITDA margin
    7.4 %     6.1 %     7.9 %                     4.3 %
                                                 
 Normalized Adjusted EBITDAR margin
    16.4 %     6.4 %     8.6 %                     12.3 %
                                                 
See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to
         
Adjusted EBITDA and Adjusted EBITDAR."
                                         
See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison."
                 


 
10 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA
and ADJUSTED EBITDAR
 
($ in thousands)
                                     
For the Six Months Ended June 30, 2012
 (unaudited)
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
 
Consolidated
 
                                     
Nonaffiliated revenue
  $ 810,923     $ 59,826     $ 44,873     $ 13     $ -     $ 915,635  
                                                 
Affiliated revenue
    -       66,267       1,550       -       (67,817 )     -  
                                                 
Total revenue
  $ 810,923     $ 126,093     $ 46,423     $ 13     $ (67,817 )   $ 915,635  
                                                 
Income (loss) from continuing operations
  $ 42,323     $ 7,313     $ 3,108     $ (47,912 )   $ -     $ 4,832  
                                                 
Income tax expense
    -       -       -       3,089       -       3,089  
                                                 
Interest, net
    (28 )     -       (3 )     8,870       -       8,839  
                                                 
Depreciation and amortization
    14,144       511       371       1,908       -       16,934  
                                                 
EBITDA
  $ 56,439     $ 7,824     $ 3,476     $ (34,045 )   $ -     $ 33,694  
                                                 
                                                 
Restructuring costs
    -       -       -       -       -       -  
                                                 
                                                 
Adjusted EBITDA
  $ 56,439     $ 7,824     $ 3,476     $ (34,045 )   $ -     $ 33,694  
                                                 
Center rent expense
    72,282       279       338       -       -       72,899  
                                                 
Adjusted EBITDAR
  $ 128,721     $ 8,103     $ 3,814     $ (34,045 )   $ -     $ 106,593  
                                                 
                                                 
Normalized Adjusted EBITDA
  $ 56,439     $ 7,824     $ 3,476     $ (32,207 )   $ -     $ 35,532  
Normalized Adjusted EBITDAR
  $ 128,721     $ 8,103     $ 3,814     $ (32,207 )   $ -     $ 108,431  
                                                 
                                                 
Adjusted EBITDA margin
    7.0 %     6.2 %     7.5 %                     3.7 %
                                                 
Adjusted EBITDAR margin
    15.9 %     6.4 %     8.2 %                     11.6 %
                                                 
 Normalized Adjusted EBITDA margin
    7.0 %     6.2 %     7.5 %                     3.9 %
                                                 
 Normalized Adjusted EBITDAR margin
    15.9 %     6.4 %     8.2 %                     11.8 %
                                                 
See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to
         
Adjusted EBITDA and Adjusted EBITDAR."
See normalizing adjustments in the table "Normalizing Adjustments - Year to Date Comparison."


 
11 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA
and ADJUSTED EBITDAR
($ in thousands)
                                     
 For the Three Months Ended June 30, 2011
 (unaudited)
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
 
Consolidated
 
                                     
Nonaffiliated revenue
  $ 418,584     $ 29,979     $ 21,998     $ 14     $ -     $ 470,575  
                                                 
Affiliated revenue
    -       33,225       699       -       (33,924 )     -  
                                                 
Total revenue
  $ 418,584     $ 63,204     $ 22,697     $ 14     $ (33,924 )   $ 470,575  
                                                 
Income (loss) from continuing operations
  $ 35,202     $ 3,427     $ 1,462     $ (28,646 )   $ -     $ 11,445  
                                                 
Income tax expense
    -       -       -       7,894       -       7,894  
                                                 
Interest, net
    (31 )     -       -       4,885       -       4,854  
                                                 
Depreciation and amortization
    6,354       227       187       861       -       7,629  
                                                 
EBITDA
  $ 41,525     $ 3,654     $ 1,649     $ (15,006 )   $ -     $ 31,822  
                                                 
Restructuring costs
    167       -       -       -       -       167  
                                                 
Adjusted EBITDA
  $ 41,692     $ 3,654     $ 1,649     $ (15,006 )   $ -     $ 31,989  
                                                 
Center rent expense
    35,453       127       170       -       -       35,750  
                                                 
Adjusted EBITDAR
  $ 77,145     $ 3,781     $ 1,819     $ (15,006 )   $ -     $ 67,739  
                                                 
                                                 
                                                 
                                                 
Adjusted EBITDA margin
    10.0 %     5.8 %     7.3 %                     6.8 %
                                                 
Adjusted EBITDAR margin
    18.4 %     6.0 %     8.0 %                     14.4 %
                                                 
                                                 
See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to
     Adjusted EBITDA and Adjusted EBITDAR."


 
12 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA
and ADJUSTED EBITDAR
 
($ in thousands)
 
                                     
For the Six Months Ended June 30, 2011
 
(unaudited)
 
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
 
Consolidated
 
                                     
Nonaffiliated revenue
  $ 832,471     $ 60,077     $ 44,314     $ 21     $ -     $ 936,883  
                                                 
Affiliated revenue
    -       65,920       1,321       -       (67,241 )     -  
                                                 
Total revenue
  $ 832,471     $ 125,997     $ 45,635     $ 21     $ (67,241 )   $ 936,883  
                                                 
Income (loss) from continuing operations
  $ 68,541     $ 6,199     $ 2,861     $ (56,538 )   $ -     $ 21,063  
                                                 
Income tax expense
    -       -       -       14,512       -       14,512  
                                                 
Interest, net
    (37 )     -       1       9,889       -       9,853  
                                                 
Depreciation and amortization
    12,560       453       374       1,690       -       15,077  
                                                 
EBITDA
  $ 81,064     $ 6,652     $ 3,236     $ (30,447 )   $ -     $ 60,505  
                                                 
Restructuring costs
    303       -       -       -       -       303  
                                                 
Adjusted EBITDA
  $ 81,367     $ 6,652     $ 3,236     $ (30,447 )   $ -     $ 60,808  
                                                 
Center rent expense
    70,845       254       343       -       -       71,442  
                                                 
Adjusted EBITDAR
  $ 152,212     $ 6,906     $ 3,579     $ (30,447 )   $ -     $ 132,250  
                                                 
                                                 
                                                 
                                                 
Adjusted EBITDA margin
    9.8 %     5.3 %     7.1 %                     6.5 %
                                                 
Adjusted EBITDAR margin
    18.3 %     5.5 %     7.8 %                     14.1 %
                                                 
                                                 
See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to
     Adjusted EBITDA and Adjusted EBITDAR."


 
13 of 16

 

Sun Healthcare Group, Inc. and Subsidiaries
Selected Operating Statistics
Continuing Operations
                                                 
   
For the
         
For the
       
   
Three Months Ended
         
Six Months Ended
       
   
June 30,
         
June 30,
       
   
2012
         
2011
         
2012
         
2011
       
Consolidated Company
                                               
                                                 
Revenues - Non-affiliated (in thousands)                                                        
Skilled Nursing and similar facilities
  $ 388,810           $ 403,221           $ 779,244           $ 802,775        
Hospice
    15,869             14,907             30,771             28,762        
Other - Inpatient Services
    456             456             908             934        
Inpatient Services
    405,135             418,584             810,923             832,471        
                                                         
Rehabilitation Therapy Services
    29,197             29,979             59,826             60,077        
Medical Staffing Services
    22,804             21,998             44,873             44,314        
Other - non-core businesses
    6             14             13             21        
Total
  $ 457,142           $ 470,575           $ 915,635           $ 936,883        
                                                         
                                                         
Revenue Mix - Non-affiliated (in thousands)
                                                               
Medicare
  $ 133,399       29 %   $ 154,193       33 %   $ 269,688       29 %   $ 305,443       33 %
Medicaid
    188,851       41 %     179,578       38 %     375,293       41 %     357,223       38 %
Private and Other
    106,376       24 %     108,343       23 %     213,636       24 %     217,629       23 %
Managed Care / Insurance
    23,405       5 %     23,347       5 %     46,743       5 %     46,356       5 %
Veterans
    5,111       1 %     5,114       1 %     10,275       1 %     10,232       1 %
Total
  $ 457,142       100 %   $ 470,575       100 %   $ 915,635       100 %   $ 936,883       100 %
                                                                 
                                                                 
Inpatient Services Stats
                                                               
                                                                 
Number of centers:
    190               190               190               190          
Number of available beds:
    20,756               20,820               20,756               20,820          
Occupancy %:
    87.2 %             87.2 %             87.2 %             87.4 %        
                                                                 
                                                                 
Payor Mix % based on patient days:
                                                               
Medicare - SNF Beds
    14.8 %             15.9 %             15.0 %             15.9 %        
Managed care / Ins. - SNF Beds
    4.1 %             4.0 %             4.0 %             4.1 %        
    Total SNF skilled mix
    18.9 %             19.9 %             19.0 %             20.0 %        
                                                                 
Medicare
    13.5 %             14.6 %             13.7 %             14.5 %        
Medicaid
    63.7 %             62.0 %             63.5 %             62.1 %        
Private and Other
    17.7 %             18.4 %             17.8 %             18.4 %        
Managed Care / Insurance
    3.8 %             3.7 %             3.7 %             3.7 %        
Veterans
    1.3 %             1.3 %             1.3 %             1.3 %        
                                                                 
Revenue Mix % of revenues:
                                                               
Medicare - SNF Beds
    30.8 %             35.2 %             31.2 %             35.1 %        
Managed care / Ins. - SNF Beds
    6.1 %             5.9 %             6.1 %             5.9 %        
    Total SNF skilled mix
    36.9 %             41.1 %             37.3 %             41.0 %        
                                                                 
Medicare
    31.8 %             35.8 %             32.1 %             35.6 %        
Medicaid
    46.6 %             42.9 %             46.3 %             42.9 %        
Private and Other
    14.6 %             14.6 %             14.6 %             14.8 %        
Managed Care / Insurance
    5.7 %             5.5 %             5.7 %             5.5 %        
Veterans
    1.3 %             1.2 %             1.3 %             1.2 %        
                                                                 
                                                                 
Revenues PPD:
                                                               
Medicare (Part A)
  $ 461.80             $ 520.51             $ 462.46             $ 521.31          
Medicare Blended Rate (Part A & B)
  $ 508.06             $ 557.95             $ 507.02             $ 558.11          
Medicaid
  $ 180.08             $ 175.49             $ 179.36             $ 174.59          
Medicaid, net of provider taxes
  $ 162.91             $ 160.19             $ 162.26             $ 159.41          
Private and Other
  $ 190.00             $ 188.15             $ 190.09             $ 192.13          
Managed Care / Insurance
  $ 371.57             $ 380.42             $ 376.47             $ 374.50          
Veterans
  $ 245.54             $ 246.89             $ 248.31             $ 246.20          
                                                                 
                                                                 
Rehab contracts
                                                               
                                                                 
Affiliated
    178               179               178               179          
Non-affiliated
    332               342               332               342          
                                                                 
Average Qtrly Revenue per Contract
(in thousands)
  $ 122             $ 121             $ 124             $ 121          
                                                                 
                                                                 


 
14 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                                           
NORMALIZING ADJUSTMENTS - QUARTER COMPARISON
(in thousands, except per share data)
                                           
                                           
   
AS REPORTED - 2nd QUARTER 2012
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
 
Net (Loss)
Income
 
                                           
As Reported 2nd QUARTER 2012
  $ 457,142     $ 54,329     $ 17,807     $ 4,874     $ 2,973     $ (3,953 )   $ (980 )
Percent of Revenue
            11.9 %     3.9 %     1.1 %     0.7 %     -0.9 %     -0.2 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
Transaction costs
    -       1,838       1,838       1,838       1,121       -       1,121  
                                                         
Normalized As Reported-2nd QUARTER 2012
$ 457,142     $ 56,167     $ 19,645     $ 6,712     $ 4,094     $ (3,953 )   $ 141  
Percent of Revenue
            12.3 %     4.3 %     1.5 %     0.9 %     -0.9 %     0.0 %
                                                         
As Reported
                                  $ 0.11     $ (0.15 )   $ (0.04 )
 Diluted EPS:             As Normalized
                                  $ 0.15     $ (0.14 )   $ 0.01  
                                                         
                                                         
                                                         
                                                         
                                                         
   
AS REPORTED - 2nd QUARTER 2011
   
Revenue
   
Adjusted EBITDAR
 
Adjusted EBITDA
 
Pre-tax
   
Income from Continuing Operations
 
Disc Ops
 
Net Income
 
                                                         
As Reported - 2nd QUARTER 2011
  $ 470,575     $ 67,739     $ 31,989     $ 19,339     $ 11,445     $ (1,499 )   $ 9,946  
Percent of Revenue
            14.4 %     6.8 %     4.1 %     2.4 %     -0.3 %     2.1 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
None
    -       -       -       -       -       -       -  
                                                         
Normalized As Reported-2nd QUARTER 2011
$ 470,575     $ 67,739     $ 31,989     $ 19,339     $ 11,445     $ (1,499 )   $ 9,946  
Percent of Revenue
            14.4 %     6.8 %     4.1 %     2.4 %     -0.3 %     2.1 %
                                                         
 As Reported
                                  $ 0.44     $ (0.06 )   $ 0.38  
Diluted EPS:             As Normalized
                                  $ 0.44     $ (0.06 )   $ 0.38  
                                                         
                                                         
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."

Normalizing adjustments are transactions or adjustments not related to ongoing operations and consist of transaction costs associated with the Company's sale to Genesis Healthcare.
 
Since normalizing adjustments are not measurements determined  in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations and interpretations, the information presented herein may not be comparable to other similarly described information of other companies.


 
15 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                                           
NORMALIZING ADJUSTMENTS - YEAR TO DATE COMPARISON
(in thousands, except per share data)
                                           
                                           
   
AS REPORTED - SIX MONTHS 2012
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
 
Net (Loss)
Income
 
                                           
As Reported - Six Months 2012
  $ 915,635     $ 106,593     $ 33,694     $ 7,921     $ 4,832     $ (5,599 )   $ (767 )
Percent of Revenue
            11.6 %     3.7 %     0.9 %     0.5 %     -0.6 %     -0.1 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
Transaction costs
    -       1,838       1,838       1,838       1,121       -       1,121  
                                                         
Normalized As Reported-Six Months 2012
$ 915,635     $ 108,431     $ 35,532     $ 9,759     $ 5,953     $ (5,599 )   $ 354  
Percent of Revenue
            11.8 %     3.9 %     1.1 %     0.7 %     -0.6 %     0.0 %
                                                         
 As Reported
                                  $ 0.18     $ (0.21 )   $ (0.03 )
Diluted EPS:              As Normalized
                                  $ 0.22     $ (0.21 )   $ 0.01  
                                                         
                                                         
                                                         
                                                         
                                                         
   
AS REPORTED - SIX MONTHS 2011
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
 
Net Income
 
                                                         
As Reported - Six Months 2011
  $ 936,883     $ 132,250     $ 60,808     $ 35,575     $ 21,063     $ (3,005 )   $ 18,058  
Percent of Revenue
            14.1 %     6.5 %     3.8 %     2.2 %     -0.3 %     1.9 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
None
    -       -       -       -       -       -       -  
                                                         
Normalized As Reported-Six Months 2011
$ 936,883     $ 132,250     $ 60,808     $ 35,575     $ 21,063     $ (3,005 )   $ 18,058  
Percent of Revenue
            14.1 %     6.5 %     3.8 %     2.2 %     -0.3 %     1.9 %
                                                         
                                                         
 As Reported
                                  $ 0.81     $ (0.11 )   $ 0.70  
Diluted EPS:              As Normalized
                                  $ 0.81     $ (0.11 )   $ 0.70  
                                                         
                                                         
                                                         
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."
 
                                                         
Normalizing adjustments are transactions or adjustments not related to ongoing operations and consist of transaction costs associated with the Company's sale to Genesis Healthcare.
 
                                                         
Since normalizing adjustments are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations and interpretations, the information presented herein may not be comparable to other similarly described information of other companies.
 

 
16 of 16